Preferential Loss of Contrast Decrement Responses in Human Glaucoma

Area of Science:

• Ophthalmology
• Neuroscience
• Visual Electrophysiology

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Animal models and human data suggest glaucoma may selectively damage OFF visual pathways.
• Further investigation is needed to confirm this preferential damage in human patients.

Purpose of the Study:

• To investigate whether glaucoma causes preferential damage to OFF visual pathways in humans.
• To compare visual pathway function in glaucoma patients and healthy controls using electrophysiology.
• To assess the potential of steady-state visual evoked potentials (SSVEPs) as a biomarker for glaucoma.

Main Methods:

• Recorded monocular steady-state visual evoked potentials (SSVEPs) from 50 glaucoma patients and 28 controls.
• Stimuli consisted of equal Weber contrast increments and decrements using sawtooth waveforms at 2.73 Hz.
• Glaucoma patients were categorized into mild and moderate to severe groups based on visual field measurements.

Main Results:

• SSVEP amplitudes were reduced in both glaucoma groups, with greater depression in the moderate to severe group.
• Decremental (OFF pathway) responses showed more significant differences between controls and moderate-severe glaucoma patients than incremental responses.
• OFF/decrement responses were faster in controls than in glaucoma patients, suggesting impaired OFF pathway function.

Conclusions:

• The findings support preferential loss of decremental responses in human glaucoma, consistent with selective OFF retinal ganglion cell damage.
• This pattern aligns with evidence from animal models, ERG, and retinal imaging.
• SSVEP shows promise as a sensitive biomarker for monitoring glaucoma progression.